Company record
Appco Pharma LLC
0 FDA warning letters since 2023 and 3 recalls in the last 12 months.
Get an email the day FDA posts anything new about Appco Pharma LLC.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Apr 8 | Class II | Appco Pharma LLC Drug |
Prazosin Hydrochloride Capsules, USP, 1mg, 100-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ, Manufactured by: Appco Pharma LLC, Piscataway, NJ, NDC 70377-066-11. cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits. FDA notice D-0419-2026 |
| Apr 8 | Class II | Appco Pharma LLC Drug |
Prazosin Hydrochloride Capsules, USP, 2mg, 100-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ, Manufactured by: Appco Pharma LLC, Piscataway, NJ, NDC 70377-067-11. cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits. FDA notice D-0420-2026 |
| Apr 8 | Class II | Appco Pharma LLC Drug |
Prazosin Hydrochloride Capsules, USP, 5mg, 100-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ, Manufactured by: Appco Pharma LLC, Piscataway, NJ, NDC 70377-068-11. cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits. FDA notice D-0421-2026 |